4.3 Letter

Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia

Journal

LEUKEMIA & LYMPHOMA
Volume 53, Issue 7, Pages 1409-1411

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2012.656105

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available